[Effect of preparation IEM-366 on the reverse development of experimental arteriosclerosis].
D000818:Animals; D001011:Aorta / Q000032:analysis / Q000378:metabolism; D001161:Arteriosclerosis / Q000139:chemically induced / Q000188:drug therapy* / Q000517:prevention & control; D002784:Cholesterol / Q000032:analysis / Q000378:metabolism; D006937:Hypercholesterolemia / Q000188:drug therapy; D006993:Hypnotics and Sedatives / Q000627:therapeutic use*; D050356:Lipid Metabolism; D008064:Lipidoses / Q000188:drug therapy; D008055:Lipids / Q000032:analysis; D008099:Liver / Q000032:analysis / Q000378:metabolism; D008297:Male; D008722:Methods; D010713:Phosphatidylcholines / Q000032:analysis; D011817:Rabbits
D006993:Hypnotics and Sedatives; D008055:Lipids; D010713:Phosphatidylcholines; D002784:Cholesterol
Vliianie preparata IEM-366 na obratnoe razvitie éksperimental'nogo ateroskleroza.